sample	event	source	type	chromosome1	bp1	chromosome2	bp2	split_reads	disc_reads	genotype	id	length(Kb)	position	configuration	allele_frequency	log2(cnv)	microhomology	inserted_seq	consensus	contig_sequence	mechanism	bp1_locus	bp2_locus	affected_genes	status	notes	snp_freq
D050R10	5	Control-Freec	DEL	3L	9102625	3L	9106160	-	-	somatic_tumour	-	3.5	3L:9102625-9106160	Heterozygous deletion	0.24	-0.94	-	-	-	-	-	bol, 3UTR	bol, intron	bol		unadj_af=0.24; snp_su:18; snp_op:2; snp_ratio:8.96; wg_del:True	26.53
D050R10	10	Control-Freec	DEL	X	11195850	X	11199385	-	-	somatic_tumour	-	3.5	X:11195850-11199385	Heterozygous deletion	0.25	-0.9	-	-	-	-	-	intergenic	intergenic	-		unadj_af=0.25; snp_su:0; snp_op:0; wg_del:True	0.0
D050R12	4	Control-Freec	DEL	3R	32031456	3R	32079331	-	-	somatic_tumour	-	47.9	3R:32031456-32079331	Heterozygous deletion	0.13	-0.48	-	-	-	-	-	intergenic	intergenic	CG2053, krz, mod, Map205		unadj_af=0.13; snp_su:25; snp_op:19; snp_ratio:1.32; wg_del:True	10.77
D050R12	6	Control-Freec	DUP	X	6268144	X	6274032	-	-	somatic_tumour	-	5.9	X:6268144-6274032	Heterozygous triplication	0.19	0.44	-	-	-	-	-	Spt6, exon_2	Spt6, exon	Spt6		unadj_af=0.19; snp_su:0; snp_op:0	0.0
D050R12	7	Control-Freec	DEL	X	11196032	X	11199344	-	-	somatic_tumour	-	3.3	X:11196032-11199344	Heterozygous deletion	0.24	-0.86	-	-	-	-	-	intergenic	intergenic	-		unadj_af=0.24; snp_su:0; snp_op:2; wg_del:True	0.0
D050R14	5	Control-Freec	DEL	3L	9102666	3L	9106596	-	-	somatic_tumour	-	3.9	3L:9102666-9106596	Heterozygous deletion	0.24	-0.94	-	-	-	-	-	bol, 3UTR	bol, 3UTR	bol		unadj_af=0.24; snp_su:20; snp_op:2; snp_ratio:9.96; wg_del:True	22.8
D050R14	9	Control-Freec	DUP	4	328941	4	330120	-	-	somatic_tumour	-	1.2	4:328941-330120	Heterozygous triplication	0.2	0.44	-	-	-	-	-	PMCA, 3UTR	PMCA, 3UTR	CG32850, PMCA		unadj_af=0.2; snp_su:0; snp_op:0	0.0
D050R16	7	Control-Freec	DUP	2R	21820177	2R	21830291	-	-	somatic_tumour	-	10.1	2R:21820177-21830291	Heterozygous triplication	0.16	0.41	-	-	-	-	-	intergenic	CG13492, intron	CG13492		unadj_af=0.16; snp_su:0; snp_op:0	0.0
D050R16	15	Control-Freec	DUP	X	9363230	X	9373733	-	-	somatic_tumour	-	10.5	X:9363230-9373733	Heterozygous triplication	0.23	0.53	-	-	-	-	-	mgl, exon_12	mgl, exon_7	mgl		unadj_af=0.23; snp_su:0; snp_op:0	0.0
D050R16	17	Control-Freec	DUP	X	20392158	X	20410830	-	-	somatic_tumour	-	18.7	X:20392158-20410830	Heterozygous triplication	0.18	0.42	-	-	-	-	-	l(1)G0004, exon	HERC2, exon_9	l(1)G0004, Syx16, HERC2		unadj_af=0.18; snp_su:0; snp_op:0	0.0
D050R18	3	Control-Freec	DUP	2L	8538675	2L	8543670	-	-	somatic_tumour	-	5.0	2L:8538675-8543670	Heterozygous triplication	0.13	0.57	-	-	-	-	-	CG17834, intron	Sema-1a, exon_1	CG17834, tRNA:Asp-GTC-1-4, tRNA:Asp-GTC-1-5, Sema-1a		unadj_af=0.13; snp_su:0; snp_op:0	0.0
D050R18	4	Control-Freec	DUP	2L	10278600	2L	10281930	-	-	somatic_tumour	-	3.3	2L:10278600-10281930	Heterozygous triplication	0.23	0.48	-	-	-	-	-	Utx, intron	intergenic	Utx, CG34043		unadj_af=0.23; snp_su:0; snp_op:0	0.0
D050R18	5	Control-Freec	DUP	2L	10291920	2L	10293585	-	-	somatic_tumour	-	1.7	2L:10291920-10293585	Heterozygous triplication	0.3	0.6	-	-	-	-	-	CG5604, intron	Hand, intron	CG5604, Hand		unadj_af=0.3; snp_su:0; snp_op:0	0.0
D050R18	6	Control-Freec	DUP	2L	10995660	2L	10997880	-	-	somatic_tumour	-	2.2	2L:10995660-10997880	Heterozygous triplication	0.37	0.78	-	-	-	-	-	CG16833, 3UTR	aub, 3UTR	CG16833, aub		unadj_af=0.37; snp_su:0; snp_op:0	0.0
D050R18	8	novobreak	BND	2L	11516068	2L	11516283	6	0	somatic_tumour	2	0.2	2L:11516068-11516283	5to5	0.11	0.0	-	-	CTTCCCTTTTTTCTACACTTCGCCACCTATCCCCATTCTCCCTACTGCCAACCCACTGCATTTTATCTAAAATAAACTGTAACTTTTTGTTAACTTTACTAGTAATACTATTTTGACCATTGCTGTATTTTTTGAAGTGTGCGAGTAAGTATGAAAAGCAAGGCATTGGAAAAACGAAACTTTCACAATTTTTGTGAAACCGCGA	-	-	Dlg5, intron	Dlg5, intron	Dlg5		unadj_af=0.11	0.0
D050R18	9	Control-Freec	DUP	2L	11793750	2L	11795970	-	-	somatic_tumour	-	2.2	2L:11793750-11795970	Heterozygous triplication	0.23	0.62	-	-	-	-	-	CG14937, exon	crol, 3UTR	CG14937, crol		unadj_af=0.23; snp_su:0; snp_op:1	0.0
D050R18	10	Control-Freec	DUP	2L	14517690	2L	14528790	-	-	somatic_tumour	-	11.1	2L:14517690-14528790	Heterozygous triplication	0.18	0.47	-	-	-	-	-	intergenic	intergenic	tRNA:Gly-GCC-1-4, tRNA:Gly-GCC-1-5, tRNA:Gly-GCC-1-6, CG33648		unadj_af=0.18; snp_su:8; snp_op:9; snp_ratio:0.89	10.44
D050R18	11	Control-Freec	DUP	2L	15032730	2L	15034950	-	-	somatic_tumour	-	2.2	2L:15032730-15034950	Heterozygous triplication	0.24	0.57	-	-	-	-	-	GABA-B-R1, 3UTR	intergenic	GABA-B-R1		unadj_af=0.24; snp_su:1; snp_op:0	12.4
D050R18	12	Control-Freec	DUP	2L	17457525	2L	17461410	-	-	somatic_tumour	-	3.9	2L:17457525-17461410	Heterozygous triplication	0.19	0.5	-	-	-	-	-	CG18563, exon	BicD, exon_8	CG5050, CG18563, BicD		unadj_af=0.19; snp_su:1; snp_op:1	5.88
D050R18	18	Control-Freec	DUP	3L	16197675	3L	16202115	-	-	somatic_tumour	-	4.4	3L:16197675-16202115	Heterozygous triplication	0.27	0.67	-	-	-	-	-	intergenic	intergenic	CG33687, CG33688, CG33689, CG33690		unadj_af=0.27; snp_su:6; snp_op:3; snp_ratio:2.0	15.54
D050R18	21	Control-Freec	DUP	3R	14618145	3R	14620920	-	-	somatic_tumour	-	2.8	3R:14618145-14620920	Heterozygous triplication	0.34	0.73	-	-	-	-	-	CG14853, 3UTR	put, 3UTR	CG14853, put		unadj_af=0.34; snp_su:0; snp_op:0	0.0
D050R18	22	novobreak	BND	3R	20367342	3R	20367486	3	0	somatic_tumour	14	0.1	3R:20367342-20367486	3to3	0.04	0.0	-	-	CCTTAGTGGAGTTCCATACCCCGCAGACCCTTCCCCAGGAAGCTCAGAAATTCCCCCCCAAACCCCAAAACAGTTCGCAAGTTTTCACAAGAGTGCCTAGCCAAAAAAGGGGGGAAGGACGCACAAGCGCCAAACGAGGCTGGCAAAACGTCGAAAACAAGAAATCAGAAAATCAGATGTAGCTGCGATTCTCACAATCGGACGCACTGATGTGTATAATGATCTTTAGCTGGGATTTAAAACG	-	-	intergenic	intergenic	-		unadj_af=0.04	0.0
D050R18	23	Control-Freec	DUP	4	235875	4	253635	-	-	somatic_tumour	-	17.8	4:235875-253635	Heterozygous triplication	0.16	0.46	-	-	-	-	-	CG1674, intron	intergenic	CG1674, dpr7		unadj_af=0.16; snp_su:0; snp_op:0	0.0
D050R18	24	Control-Freec	DUP	4	570540	4	572205	-	-	somatic_tumour	-	1.7	4:570540-572205	24:24_25	0.35	0.64	-	-	-	-	-	ND-49, intron	Ephrin, intron	ND-49, Ephrin		unadj_af=0.35; snp_su:0; snp_op:0	0.0
D050R18	26	Control-Freec	DUP	4	810855	4	812520	-	-	somatic_tumour	-	1.7	4:810855-812520	26:26_27	0.36	0.67	-	-	-	-	-	Sox102F, intron	Sox102F, intron	Sox102F		unadj_af=0.36; snp_su:0; snp_op:0	0.0
D050R18	26	Control-Freec	DUP	4	812520	4	831945	-	-	somatic_tumour	-	19.4	4:812520-831945	27:26_27	0.14	0.43	-	-	-	-	-	Sox102F, intron	Sox102F, intron	Sox102F		unadj_af=0.14; snp_su:0; snp_op:0	0.0
D050R18	28	Control-Freec	DUP	4	892995	4	897435	-	-	somatic_tumour	-	4.4	4:892995-897435	28:28_29	0.25	0.56	-	-	-	-	-	unc-13, intron	unc-13, intron	unc-13		unadj_af=0.25; snp_su:0; snp_op:0	0.0
D050R18	31	Control-Freec	DUP	X	13071915	X	13074690	-	-	somatic_tumour	-	2.8	X:13071915-13074690	Heterozygous triplication	0.26	0.54	-	-	-	-	-	rad, intron	rad, intron	rad		unadj_af=0.26; snp_su:0; snp_op:0	0.0
D050R20	1	novobreak	BND	2L	15334268	2L	15343758	7	0	somatic_tumour	2	9.5	2L:15334268-15343758	5to5	0.05	0.17	-	-	GCTCTAGGCATCCTCTGCACCTGAAAAAATTATTCAGTATCCTAGAATACGCTGTATAAATGGTATATGCAAGCTAGAAGTAATCAAAACAGTTAGGCTGATCAACGTCAGCGATTGTTGCGAGGACGAGGGTGTGGATGTGGATCATACAGATGATGAACACATCGAGGAAGAGGACGAGGACGTCGATGTGGATGTGGACTCGGACCCCAATCAGACCCAGGCTGCGGCT	-	-	esg, exon	intergenic	esg		unadj_af=0.05	0.0
D050R20	5	novobreak	BND	3L	12212180	3L	12212290	4	0	somatic_tumour	7	0.1	3L:12212180-12212290	3to3	0.03	0.0	-	-	GTTGCGGCGAATAGTATTTGAAGTCCGTGGGCGCCGGCGCTTGCGGCGCCGCAGTGTGTATGGTGGTCAGAGTGCTGTTGCTGGCGGAGATTGCTCCGCTGGCCTGCAGCTGCAGCGTCGACGGGCGTCGTGGCGCCAGCGGCACCAATACCGGTACCGGCACTGGTACGGGTGGTTCCTCCTCCTCCGCCACCACCACCG	-	-	app, exon	app, exon	app		unadj_af=0.03	0.0
D050R20	6	lumpy	DEL	3L	21411443	3L	21412383	11	2	somatic_tumour	4949	0.9	3L:21411443-21412383	5to3	0.09	-0.2	-	-	-	-	-	rgn, intron	rgn, intron	rgn		unadj_af=0.09; wg_del:True	0.0
D050R20	7	Control-Freec	DUP	3R	5147556	3R	5151408	-	-	somatic_tumour	-	3.9	3R:5147556-5151408	Heterozygous triplication	0.32	0.71	-	-	-	-	-	intergenic	dpr16, intron	dpr16		unadj_af=0.32; snp_su:0; snp_op:2	0.0
D050R20	13	Control-Freec	DUP	4	798220	4	799504	-	-	somatic_tumour	-	1.3	4:798220-799504	Heterozygous triplication	0.24	0.49	-	-	-	-	-	intergenic	intergenic	-		unadj_af=0.24; snp_su:0; snp_op:1	0.0
D050R20	15	Control-Freec	DUP	X	10435068	X	10436352	-	-	somatic_tumour	-	1.3	X:10435068-10436352	Heterozygous triplication	0.32	0.44	-	-	-	-	-	CG32683, intron	CG32683, intron	CG32683		unadj_af=0.32; snp_su:0; snp_op:0	0.0
D050R20	17	novobreak	TRA	X	10822149	3R	22494715	3	0	somatic_tumour	52	11672.6	X:10822149 3R:22494715	5to5	0.05	0.0	-	-	GAGTTGTCACCTACACAAAAATCAATAACGAAACCCAATAAAATAAAATCCCACTAAATACTGTTCCATATATCAAGGCTTAACCGTAGAAGCAACAGCCATAAAGTCCGGCTGATTGCAAACAATTCCGATTGATTTATTGTGGCAATGGTTAATAC	-	-	Imp, intron	intergenic	Imp		unadj_af=0.05	0.0
D050R20	21	Control-Freec	DEL	X	21557932	X	21571200	-	-	somatic_tumour	-	13.3	X:21557932-21571200	Heterozygous deletion	0.16	-0.55	-	-	-	-	-	intergenic	intergenic	-		unadj_af=0.16; snp_su:0; snp_op:0; wg_del:True	0.0
D050R22	1	novobreak	DEL	2L	140255	2L	144791	3	0	somatic_tumour	1	4.5	2L:140255-144791	5to3	0.01	-0.12	-	-	AAAGGCCCATCGGGTCTATCTGGGGCGGCTGCTAAGAATTCAAAAAACTGGTCCGACAACTCTTTCATTCGGGCTACAAGTCTGGAGTCTACCAAGTCGTCACATTCCTGCTGAAGGCTGGTGGACTTCAGCGAGAACAGCTCCGCAGCTGCTTGGCAGGAAGCTCGAGCTACTTGGG	-	-	CG31975, exon_1	CG42399, exon	ND-15, CG31976, CG31975, CG42399		unadj_af=0.01; bp1_roo_BEL=13; wg_del:True	0.0
D050R22	2	delly	DEL	2L	3788744	2L	3790516	12	1	somatic_tumour	DEL00000000	1.8	2L:3788744-3790516	5to3	0.1	-0.03	6	-	GGGCAATAATTAGACCTCAAACGAGCATAAAATTGTTTAGCCAATTGGCATTATTCTAACAACATTAGTTCAGAGGGTTGTTGAACTCTTCGGTAGAACGGAAACTAAACCTTTTCCCCCAAACAGCTGTTAAATAATCACGAAACTGCCATGGCGAATGTGTAATAAAAACCGTTAGTGAAGTAGTTAATTGAAAGCAAAAATAAACCA	-	-	bark, intron	bark, intron	bark		unadj_af=0.1; wg_del:True	0.0
D050R22	2	lumpy	DEL	2L	3788744	2L	3790516	12	1	somatic_tumour	512	1.8	2L:3788744-3790516	5to3	0.1	-0.03	-	-	-	-	-	bark, intron	bark, intron	bark		unadj_af=0.1; wg_del:True	0.0
D050R22	3	Control-Freec	DUP	2R	3897936	2R	3943296	-	-	somatic_tumour	-	45.4	2R:3897936-3943296	Heterozygous triplication	0.1	0.28	-	-	-	-	-	intergenic	uex, exon_3	uex	T	unadj_af=0.1; low FC; snp_su:10; snp_op:4; snp_ratio:2.5	11.97
D050R22	4	Control-Freec	DUP	2R	10492776	2R	10499832	-	-	somatic_tumour	-	7.1	2R:10492776-10499832	Heterozygous triplication	0.2	0.51	-	-	-	-	-	lola, intron	lola, intron	lola		unadj_af=0.2; snp_su:0; snp_op:5; snp_ratio:0.0	0.0
D050R22	10	Control-Freec	DUP	4	71568	4	75600	-	-	somatic_tumour	-	4.0	4:71568-75600	Heterozygous triplication	0.22	0.56	-	-	-	-	-	pan, intron	pan, intron	pan		unadj_af=0.22; snp_su:1; snp_op:1	5.01
D050R22	11	Control-Freec	DUP	4	553392	4	577584	-	-	somatic_tumour	-	24.2	4:553392-577584	Heterozygous triplication	0.13	0.33	-	-	-	-	-	Thd1, exon_2	Ephrin, 3UTR	Thd1, CR43958, Pur-alpha, ND-49, Ephrin	T	unadj_af=0.13; low FC; snp_su:6; snp_op:2; snp_ratio:2.99	14.3
D050R22	12	Control-Freec	DUP	4	983808	4	988848	-	-	somatic_tumour	-	5.0	4:983808-988848	Heterozygous triplication	0.16	0.41	-	-	-	-	-	intergenic	intergenic	-		unadj_af=0.16; snp_su:0; snp_op:1	0.0
D050R22	13	Control-Freec	DUP	4	1051848	4	1054368	-	-	somatic_tumour	-	2.5	4:1051848-1054368	Heterozygous triplication	0.24	0.52	-	-	-	-	-	CaMKII, intron	intergenic	CaMKII		unadj_af=0.24; snp_su:0; snp_op:0	0.0
D050R22	15	Control-Freec	DUP	X	3335976	X	3354624	-	-	somatic_tumour	-	18.6	X:3335976-3354624	Heterozygous triplication	0.21	0.53	-	-	-	-	-	CR44886, ncRNA	intergenic	dnc, CR44886		unadj_af=0.21; snp_su:0; snp_op:0	0.0
D050R22	17	novobreak	BND	X	15470322	X	15495936	7	0	somatic_tumour	8	25.6	X:15470322-15495936	5to5	0.08	0.02	-	-	ATATAACTTCATATATAGCTAGTTATATTGATAATATACCATATAAAAAAAGGTTAACCAATGCAGGGATATAACAGTTACTATTTTAAGACCACTTTTCCATTGATCATTGATCGTTTTGGAAAAATACCACAAATAGTTTTACCAACACCACCAGCTGGCTAAAATGTTCCCTGAACTCAATCGTAAAACGGATCAGTGTATTTTTCGCTGGATCCTTATTGACACGATCCTCGTAAGCGATGAGGAGCTGGCAAATGGGCTGGACAAGATCTCTCAGGCCGTATGCAAAGA	-	-	Grip128, exon_4	Gmap, intron	Grip128, Gmap		unadj_af=0.08	0.0
D050R24	17	Control-Freec	DEL	3L	0	3L	106488	-	-	somatic_tumour	-	106.5	3L:0-106488	Heterozygous deletion	0.16	-0.53	-	-	-	-	-	intergenic	intergenic	mthl8, CG43149, Lsp1gamma, CR44510, CR44511, CR43150, CR43988, CG13405, CG12483		unadj_af=0.16; snp_su:46; snp_op:38; snp_ratio:1.21; wg_del:True	10.51
D050R24	31	Control-Freec	DUP	3R	11371248	3R	11376990	-	-	somatic_tumour	-	5.7	3R:11371248-11376990	Heterozygous triplication	0.36	0.74	-	-	-	-	-	pros, intron	pros, exon_5	pros		unadj_af=0.36; snp_su:0; snp_op:1	0.0
D050R24	34	Control-Freec	DUP	3R	24318414	3R	24329376	-	-	somatic_tumour	-	11.0	3R:24318414-24329376	Heterozygous triplication	0.23	0.54	-	-	-	-	-	Nab2, 5UTR	CG5728, exon_3	Nab2, CR46093, BRWD3, CG5728		unadj_af=0.23; snp_su:1; snp_op:1	9.28
D050R24	40	Control-Freec	DEL	4	266220	4	292320	-	-	somatic_tumour	-	26.1	4:266220-292320	Heterozygous deletion	0.14	-0.41	-	-	-	-	-	intergenic	Syt7, intron	NfI, CR44023, Syt7		unadj_af=0.14; snp_su:0; snp_op:0; wg_del:True	0.0
D050R24	41	Control-Freec	DEL	4	728190	4	729756	-	-	somatic_tumour	-	1.6	4:728190-729756	Heterozygous deletion	0.2	-0.71	-	-	-	-	-	bt, exon_5	bt, intron	bt		unadj_af=0.2; snp_su:0; snp_op:0; wg_del:True; wg_del:True	0.0
D050R24	42	Control-Freec	DEL	4	898362	4	903582	-	-	somatic_tumour	-	5.2	4:898362-903582	Heterozygous deletion	0.13	-0.42	-	-	-	-	-	unc-13, intron	unc-13, intron	unc-13		unadj_af=0.13; snp_su:0; snp_op:0; wg_del:True; wg_del:True	0.0
D050R24	44	Control-Freec	DUP	X	2724840	X	2737890	-	-	somatic_tumour	-	13.1	X:2724840-2737890	Heterozygous triplication	0.24	0.51	-	-	-	-	-	fs(1)Ya, exon	crm, intron	fs(1)Ya, vilya, dwg, ttm50, CG2712, crm		unadj_af=0.24; snp_su:0; snp_op:0	0.0
D050R24	45	Control-Freec	DUP	X	4619700	X	4660416	-	-	somatic_tumour	-	40.7	X:4619700-4660416	Heterozygous triplication	0.2	0.48	-	-	-	-	-	peb, intron	CG3009, exon_2	peb, CG12184, CG12179, pon, CG3081, CG3062, HLH4C, mRpL30, Torsin, Cbp80, CG15473, CG3009		unadj_af=0.2; snp_su:1; snp_op:0	21.43
D050R24	48	Control-Freec	DUP	X	5312916	X	5329098	-	-	somatic_tumour	-	16.2	X:5312916-5329098	Heterozygous triplication	0.24	0.55	-	-	-	-	-	dhd, 3UTR	CG3309, exon_1	dhd, CG4198, CG15930, Sas10, Rnp4F, Mcm3, CG3309		unadj_af=0.24; snp_su:0; snp_op:0	0.0
D050R24	49	Control-Freec	DUP	X	6083388	X	6114708	-	-	somatic_tumour	-	31.3	X:6083388-6114708	Heterozygous triplication	0.21	0.5	-	-	-	-	-	Mipp2, 3UTR	Ca-alpha1T, exon_19	raptor, Mipp2, CR44959, Nep1, Ca-alpha1T		unadj_af=0.21; snp_su:0; snp_op:1	0.0
D050R24	50	Control-Freec	DUP	X	8125452	X	8168256	-	-	somatic_tumour	-	42.8	X:8125452-8168256	Heterozygous triplication	0.21	0.47	-	-	-	-	-	cyr, intron	CG2278, exon	cyr, CG2116, CG10958, CG2120, Smox, CG17982, alpha-PheRS, CG2129, CG15336, CG10959, Gbeta5, CG18262, Traf6, GIIIspla2, CG15337, CG10761, CR45536, Or7a, CG2278		unadj_af=0.21; snp_su:0; snp_op:0	0.0
D050R24	51	Control-Freec	DUP	X	10465578	X	10470798	-	-	somatic_tumour	-	5.2	X:10465578-10470798	Heterozygous triplication	0.35	0.75	-	-	-	-	-	nocte, intron	nocte, exon_4	nocte		unadj_af=0.35; snp_su:0; snp_op:0	0.0
D050R24	52	Control-Freec	DUP	X	11110248	X	11128518	-	-	somatic_tumour	-	18.3	X:11110248-11128518	Heterozygous triplication	0.33	0.67	-	-	-	-	-	Hsp60A, exon_2	Gtp-bp, exon_2	Hsp60A, CG11122, Rpt3, Gtp-bp		unadj_af=0.33; snp_su:0; snp_op:0	0.0
D050R24	54	Control-Freec	DUP	X	15453288	X	15474690	-	-	somatic_tumour	-	21.4	X:15453288-15474690	Heterozygous triplication	0.19	0.46	-	-	-	-	-	intergenic	mh, exon_3	CG11655, shtd, CG6299, CG6294, CG15642, CG15641, Grip128, CG6308, mh		unadj_af=0.19; snp_su:0; snp_op:0	0.0
D050R24	56	Control-Freec	DUP	X	17661870	X	17667090	-	-	somatic_tumour	-	5.2	X:17661870-17667090	Heterozygous triplication	0.47	0.94	-	-	-	-	-	beta-Spec, exon_2	beta-Spec, exon_2	beta-Spec		unadj_af=0.47; snp_su:0; snp_op:0	0.0
D050R24	59	Control-Freec	DUP	X	19855314	X	19864188	-	-	somatic_tumour	-	8.9	X:19855314-19864188	Heterozygous triplication	0.44	0.83	-	-	-	-	-	Nup205, exon_6	CG15618, exon_4	Nup205, CG15618		unadj_af=0.44; snp_su:1; snp_op:1	5.12
D050R24	60	Control-Freec	DUP	X	20392452	X	20442564	-	-	somatic_tumour	-	50.1	X:20392452-20442564	Heterozygous triplication	0.2	0.43	-	-	-	-	-	Syx16, exon	CG1695, exon_5	Syx16, HERC2, CG15459, CG15458, Obp19a, Obp19b, Obp19c, Obp19d, Pp4-19C, cactin, CG15456, CG11710, mal, CG1695		unadj_af=0.2; snp_su:0; snp_op:0	0.0